Is this you? Create Your Porfile
Avatar

Jorg Kroll

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jorg Kroll is active.

Explore More

Publication

Featured researches published by Jorg Kroll.

Journal of the National Cancer Institute | 2004

Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer

Jens Hoffmann; Rolf Bohlmann; Nikolaus Heinrich; Helmut Hofmeister; Jorg Kroll; Hermann Künzer; Rosemarie Lichtner; Yuki Nishino; Karsten Parczyk; Gerhard Sauer; Hille Gieschen; Hannes-F. Ulbrich; Martin R. Schneider

Archive | 1998

11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA- SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS

Rolf Bohlmann; Nikolaus Heinrich; Helmut Hofmeister; Jorg Kroll; Hermann Künzer; Gerhard Sauer; Ludwig Zorn; Karl-Heinrich Fritzemeier; Monika Lessl; Rosemarie Lichtner; Yukishige Nishino; Karsten Parczyk; Martin Schneider

Archive | 1999

Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments

Rolf Bohlmann; Jorg Kroll; Hermann Künzer; Karl-Heinrich Fritzemeier; Christa Hegele-Hartung; Rudolf Knauthe; Monika Lessl; Rosemarie Lichtner; Yukishige Nishino; Karsten Parczyk; Martin Schneider

Archive | 2002

Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer

Martin Krüger; Olaf Prien; Andreas Steinmeyer; Jorg Kroll; Alexander Ernst; Gerhard Siemeister; Martin Haberey; Jens Hoffmann

Archive | 2005

17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for their production, use of the 17alpha-alkyl-17beta-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations

Rolf Bohlmann; Nikolaus Heinrich; Rolf Jautelat; Jorg Kroll; Orlin Petrov; Andreas Reichel; Jens Hoffmann; Rosemarie B. Lichtner

Archive | 1999

7 α-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 α(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents

Dieter Bittler; Rolf Bohlmann; Nikolaus Heinrich; Jorg Kroll; Gerhard Sauer; Yukishige Nishino; Karsten Parczyk; Martin Schneider; Christa Hegele-Hartung; Rosemarie Lichtner

Archive | 2005

Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents

Rolf Bohlmann; Jorg Kroll; Hermann Kuenzer; Christa Hegele-Hartung; Monika Lessl; Rosemarie B. Lichtner; Yukishige Nishino

Archive | 1993

3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs

Dieter Bittler; Helmut Hofmeister; Thomas Brumby; Jorg Kroll; Hermann Künzer; Gerhard Sauer; Karl-Heinrich Fritzemeier; Horst Michna

Archive | 1998

11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

Rolf Bohlmann; Nikolaus Heinrich; Helmut Hofmeister; Jorg Kroll; Hermann Künzer; Gerhard Sauer; Ludwig Zorn; Karl-Heinrich Fritzemeier; Monika Lessl; Rosemarie Lichtner; Yukishige Nishino; Karsten Parczyk; Martin Schneider

Archive | 1997

7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS

Dieter Bittler; Rolf Bohlmann; Christa Hegele-Hartung; Nikolaus Heinrich; Jorg Kroll; Rosemarie Lichtner; Yukishige Nishino; Karsten Parczyk; Gerhard Sauer; Martin Schneider

Explore More

Collaboration

Dive into the Jorg Kroll's collaboration.

Top Co-Authors
Avatar

Rolf Bohlmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Rosemarie Lichtner

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Jens Hoffmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Nikolaus Heinrich

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Gerhard Sauer

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Andreas Reichel

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Orlin Petrov

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Rolf Jautelat

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Christa Hegele-Hartung

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Karl-Heinrich Fritzemeier

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge